A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel

NCT00131963 · clinicaltrials.gov ↗

COMPLETED

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: cyclophosphamide
DRUG: doxorubicin
DRUG: paclitaxel

Sponsor

Duke University

Collaborators

[object Object]